Heron Therapeutics Stock News

BidaskClub cut shares of Heron Therapeutics (NASDAQ:HRTX) from a sell rating to a strong sell rating in a report released on Friday, BidAskClub reports. Other analysts also recently issued reports abo

The "Postoperative Pain - Market Insights, Epidemiology and Market Forecast - 2028" report has been added to ResearchAndMarkets.com's offering.

DUBLIN--(BUSINESS WIRE)--The "Postoperative Pain - Market Insights, Epidemiology and Market Forecast - 2028" report has been added to ResearchAndMarkets.com's offering. This report delivers an in-dept

If you own shares in Heron Therapeutics, Inc. (NASDAQ:HRTX) then it's worth thinking about how it contributes to the...

Dublin, Feb. 10, 2020 -- The "Postoperative Pain - Market Insights, Epidemiology and Market Forecast - 2028" report has been added to ResearchAndMarkets.com's.

Heron Therapeutics Inc (NASDAQ:HRTX) has received a consensus recommendation of “Buy” from the ten analysts that are currently covering the stock, Marketbeat Ratings reports. One research analyst

. .. ... . ... . FG FT Reb ST. JOHN'S Min M-A M-A O-T A PF PTS Roberts 7 1-2 0-0 2-2 0 0 2 Dunn 31 2-12 2-3 3-5 6 2 6 Williams 28 ..

ValuEngine cut shares of Heron Therapeutics (NASDAQ:HRTX) from a strong-buy rating to a buy rating in a research note issued to investors on Tuesday, ValuEngine reports. HRTX has been the subject of s

So far Tuesday, February 4, NASDAQ is up 2.55% and the S&P is up 1.73%. Let’s take a look at

Heron Therapeutics Inc (NASDAQ:HRTX) – Stock analysts at Svb Leerink boosted their FY2019 earnings per share (EPS) estimates for shares of Heron Therapeutics in a note issued to investors on Monday,

... . ... . .. ... FG FT Reb VILLANOVA Min M-A M-A O-T A PF PTS Gillespie 37 7-14 0-0 1-13 6 1 17 Robinson-Earl 36 5-8 1-2 3-13 1 2 13

The most you can lose on any stock (assuming you don't use leverage) is 100% of your money. But when you pick a…